Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

862
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
862
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
450
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

893
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
893
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

925
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
925
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

431
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
431

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Application of virtual simulations in the practical teaching of clinical microbiology laboratory courses.

BMC medical education·2025
Same author

Intestine epithelial cell-derived extracellular vesicles alleviate inflammation induced by <i>Clostridioides difficile</i> TcdB through the activity of TGF-β1.

Molecular & cellular toxicology·2022
Same author

Identification of a xylose-inducible promoter and its application for improving vitamin B<sub>12</sub> production in Sinorhizobium meliloti.

Biotechnology and applied biochemistry·2020
Same author

Epidemiological analysis and rapid detection by one-step multiplex PCR assay of Haemophilus influenzae in children with respiratory tract infections in Zhejiang Province, China.

BMC infectious diseases·2018
Same author

Novel Superhard sp^{3} Carbon Allotrope from Cold-Compressed C_{70} Peapods.

Physical review letters·2017
Same author

Efficient Conversion of Fructose-Based Biomass into Lipids with Trichosporon fermentans Under Phosphate-Limited Conditions.

Applied biochemistry and biotechnology·2017

相关实验视频

Updated: Jan 9, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.4K

咖啡因和IBD风险:一个元分析.

Xiangying Wu1,2, Jinqin Jiang1,2, Qin Lu1,2

  • 1Department of Rehabilitation, Jingmen Central Hospital, Jingmen, Hubei, China.

Journal of gastroenterology and hepatology
|November 30, 2025
PubMed
概括

咖啡因摄入量没有显示出与炎症性肠病 (IBD) 风险的总体联系,但区域和人口因素很重要. 咖啡和茶可以降低性结肠炎的风险,而咖啡因可能会增加美国人和青少年的风险.

科学领域:

  • 胃肠病学 胃肠病学
  • 营养科学 营养科学
  • 流行病学 流行病学

背景情况:

  • 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),包括具有潜在遗传,环境和饮食联系的慢性肠道疾病.
  • 以前关于咖啡因摄入量和IBD风险的研究产生了相互矛盾的结果,需要进一步调查.

研究的目的:

  • 系统地审查和对现有研究进行元分析,以澄清咖啡因消费与IBD发展风险之间的关联.
  • 探索潜在的缓和因素,如地理区域,年龄,咖啡因来源,吸烟状态和教育水平.

主要方法:

  • 在多个数据库 (CNKI,VIP,Wanfang,PubMed,Embase,JBI,WOS) 进行了全面的文献搜索,截至2024年5月21日.
  • 包括的研究是前性,横截面和病例对照设计,检查咖啡因摄入量和IBD风险.
  • 数据提取和质量评估由两位研究人员独立进行,并使用Stata 16.0.0进行元分析.

主要成果:

  • 对21项研究 (13,209名参与者) 的元分析发现,咖啡因摄入量与IBD风险之间没有显著的总体关联 (RR=0.84).
  • 然而,咖啡因摄入量与美国人的UC风险增加68% (RR=1.68) 以及在18岁以下的个人中增加4.52倍的IBD风险 (RR=4.52).
  • 相反,咖啡 (RR=0.43) 和茶 (RR=0.54) 消费与降低UC风险有关,而咖啡因在吸烟者中增加了80%的CD风险 (RR=1.80).
关键词:
克罗恩氏病 克罗恩氏病是什么?咖啡因 咖啡因是一种咖啡因.炎症性肠病是一种炎症性肠病.这是一个元分析.系统性审查性结肠炎

更多相关视频

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

10.4K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.5K

相关实验视频

Last Updated: Jan 9, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.4K
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

10.4K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.5K

结论:

  • 咖啡因对IBD风险的影响是复杂的,受地理位置,年龄,咖啡因来源,吸烟习惯和教育背景的影响.
  • 咖啡和茶可以在亚洲和欧洲人群中提供对UC的保护作用.
  • 咖啡因消费,特别是在美国人口和青少年中,可能会增加UC风险,强调需要个性化风险评估.